AAAAAA

   
Results: 1-19 |
Results: 19

Authors: Tagliavini, F Forloni, G D'Ursi, P Bugiani, O Salmona, M
Citation: F. Tagliavini et al., Studies on peptide fragments of prion proteins, ADV PROTEIN, 57, 2001, pp. 171

Authors: Caramelli, M Ru, G Casalone, C Bozzetta, E Acutis, PL Calella, A Forloni, G
Citation: M. Caramelli et al., Evidence for the transmission of scrapie to sheep and goats from a vaccineagainst Mycoplasma agalactiae, VET REC, 148(17), 2001, pp. 531-536

Authors: Terreni, L Calabrese, E Calella, AM Forloni, G Mariani, C
Citation: L. Terreni et al., New mutation (RA2P) of the parkin gene in the ubiquitinlike domain associated with parkinsonism, NEUROLOGY, 56(4), 2001, pp. 463-466

Authors: Forloni, G Colombo, L Girola, L Tagliavini, F Salmona, M
Citation: G. Forloni et al., Anti-amyloidogenic activity of tetracyclines: studies in vitro, FEBS LETTER, 487(3), 2001, pp. 404-407

Authors: Awan, T Forloni, G Ragg, E Iussich, S Rossi, G Colombo, L Girola, L Massignan, T Bugiani, O Salmona, M Tagliavini, F
Citation: T. Awan et al., Therapeutic approaches to prion diseases: In vitro studies with tetracycline compounds, ALZHEIMER'S DISEASE, 2001, pp. 809-820

Authors: Martin, TR Calella, AM Silva, S Munna, E Modena, P Chiesa, R Terrevazzi, S Ruggieri, RM Palermo, R Piccoli, F Confalonieri, R Tiraboschi, P Fragiacomo, C Quadri, P Lucca, U Forloni, G
Citation: Tr. Martin et al., Apolipoprotein E and intronic polymorphism of presenilin 1 and alpha-1-antichymotrypsin in Alzheimer's disease and vascular dementia, DEMENT G C, 11(5), 2000, pp. 239-244

Authors: Thellung, S Florio, T Villa, V Corsaro, A Arena, S Amico, C Robello, M Salmona, M Forloni, G Bugiani, O Tagliavini, F Schettini, G
Citation: S. Thellung et al., Apoptotic cell death and impairment of L-type voltage-sensitive calcium channel activity in rat cerebellar granule cells treated with the prion protein fragment 106-126, NEUROBIOL D, 7(4), 2000, pp. 299-309

Authors: Thellung, S Florio, T Corsaro, A Arena, S Merlino, M Salmona, M Tagliavini, F Bugiani, O Forloni, G Schettini, G
Citation: S. Thellung et al., Intracellular mechanisms mediating the neuronal death and astrogliosis induced by the prion protein fragment 106-126, INT J DEV N, 18(4-5), 2000, pp. 481-492

Authors: Forloni, G Bertani, I Calella, AM Thaler, F Invernizzi, R
Citation: G. Forloni et al., alpha-synuclein and Parkinson's disease: Selective neurodegenerative effect of alpha-synuclein fragment on dopaminergic neurons in vitro and in vivo, ANN NEUROL, 47(5), 2000, pp. 632-640

Authors: Morara, S Rosina, A Provini, L Forloni, G Caretti, A Wimalawansa, SJ
Citation: S. Morara et al., Calcitonin gene-related peptide receptor expression in the neurons and glia of developing rat cerebellum: An autoradiographic and immunohistochemicalanalysis, NEUROSCIENC, 100(2), 2000, pp. 381-391

Authors: Saez-Valero, J Angeretti, N Forloni, G
Citation: J. Saez-valero et al., Caspase-3 activation by beta-amyloid and prion protein peptides is independent from their neurotoxic effect, NEUROSCI L, 293(3), 2000, pp. 207-210

Authors: Borghi, R Marchese, R Negro, A Marinelli, L Forloni, G Zaccheo, D Abbruzzese, G Tabaton, M
Citation: R. Borghi et al., Full length alpha-synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjects, NEUROSCI L, 287(1), 2000, pp. 65-67

Authors: Galbete, JL Rodriguez-Martin, T Peressini, E Modena, P Bianchi, R Forloni, G
Citation: Jl. Galbete et al., Cholesterol decreases secretion of the secreted form of amyloid precursor protein by interfering with glycosylation in the protein secretory pathway, BIOCHEM J, 348, 2000, pp. 307-313

Authors: Tagliavini, F Forloni, G Colombo, L Rossi, G Girola, L Canciani, B Angeretti, N Giampaolo, L Peressini, E Awan, T De Gioia, L Ragg, E Bugiani, O Salmona, M
Citation: F. Tagliavini et al., Tetracycline affects abnormal properties of synthetic PrP peptides and PrPSc in vitro, J MOL BIOL, 300(5), 2000, pp. 1309-1322

Authors: Forloni, G Salmona, M Bugiani, O Tagliavini, F
Citation: G. Forloni et al., Comment on: Neurotoxicity of prion peptide 106-126 not confirmed, by Beat Kunz, Erika Sandmeier, Philipp Christen - FEBS Letters 485 (1999) 65-68, FEBS LETTER, 466(1), 2000, pp. 205-206

Authors: Forloni, G Angeretti, N Malesani, P Peressini, E Martin, TR Della Torre, P Salmona, M
Citation: G. Forloni et al., Influence of mutations associated with familial prion-related encephalopathies on biological activity of prion protein peptides, ANN NEUROL, 45(4), 1999, pp. 489-494

Authors: Salmona, M Malesani, P De Gioia, L Gorla, S Bruschi, M Molinari, A Della Vedova, F Pedrotti, B Marrari, MA Awan, T Bugiani, O Forloni, G Tagliavini, F
Citation: M. Salmona et al., Molecular determinants of the physicochemical properties of a critical prion protein region comprising residues 106-126, BIOCHEM J, 342, 1999, pp. 207-214

Authors: Ragg, E Tagliavini, F Malesani, P Monticelli, L Bugiani, O Forloni, G Salmona, M
Citation: E. Ragg et al., Determination of solution conformations of PrP106-126, a neurotoxic fragment of prion protein, by H-1 NMR and restrained molecular dynamics, EUR J BIOCH, 266(3), 1999, pp. 1192-1201

Authors: Tagliavini, F Salmona, M Forloni, G Malesani, P Giaccone, G Canciani, B McArthur, R Lansen, J Piccardo, P Dlouhy, SR Ghetti, B Frangione, B Prelli, F Bugiani, O
Citation: F. Tagliavini et al., Prion diseases: PrP peptides, pathogenesis and treatment perspectives, PRIONS: MOLECULAR AND CELLULAR BIOLOGY, 1997, pp. 125-138
Risultati: 1-19 |